News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS): Strategic Goals on Track; Development Head Officially Quits for Gates Charity


9/13/2011 8:52:04 AM

Novartis is losing its respected head of global development Trevor Mundel to the Bill & Melinda Gates Foundation, creating a temporary gap at the top of its new-drugs machine. Novartis said on Tuesday a successor for Mundel, who will stay with the Swiss drugmaker until December 1, would be named shortly. Mundel, 51, is to replace another one-time pharmaceutical executive, GlaxoSmithKline's former research head Tachi Yamada, as executive director for global health at the charity established by Microsoft founder and chairman Bill Gates.

Read at Reuters
Read at Bloomberg
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES